Bloomberg News: Administration's Studies of New Payment Systems Employ Faulty Data Analysis

The government's release of first-year cost-savings results for its accountable care organization (ACO) project and the Centers for Medicare and Medicaid Services (CMS) Innovation Center delivery system reform pilot projects have drawn criticism from both the New York Times and the Washington Post, which published articles pointing out the problems with drawing conclusions from studies that are not true randomized controlled trials. In short, correlation is not causation, and the early results, while interesting, are not the same as proof that ACOs and new reimbursement methods like bundled payments actually deliver better care more cheaply. In a commentary, Bloomberg News summarized the controversy.

Around the web

A string of executive orders from the White House created serious concerns among radiologists and other healthcare providers throughout the United States. The American College of Radiology issued a statement to help guide its members through the chaos. 

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025. 

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.